Ampersand Biomedicines
Latest round
- Series B
Last raised
- Mar 2025
Total raised
- $115M
Investors
- 2
About Ampersand Biomedicines
Based in Massachusetts, US, and founded in 2020 by Noubar Afeyan, Ampersand Biomedicines, Inc. operates as a biotechnology research company that develops DNA-based diagnostics technologies using nucleic acid testing methods and offers assays for several diseases. In March 2025, Ampersand Biomedicines, Inc. As of March 2023, Avak Kahvejian is the Chief Executive Officer (CEO) of the company. Ampersand Biomedicines, Inc. is an inventor of medicines and body therapeutics that work at the site of disease. The company combines a localizing element that allows for disease-specific precision with a sensor designed specifically for disease modification, allowing researchers to examine many different areas of diseases in almost every area of the body. Additionally, the firm develops a platform named as AND-Platform that enables a new way of designing medicines that address, navigate, and designs the characterization of human biology, spanning healthy and diseased states.
Who invested in Ampersand Biomedicines
2 investors across 2 rounds
See all investors in Ampersand Biomedicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ampersand Biomedicines
Who invested in Ampersand Biomedicines?
Ampersand Biomedicines has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ampersand Biomedicines raised?
Ampersand Biomedicines has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ampersand Biomedicines last raise money?
Ampersand Biomedicines's most recent round on record is a Series B, in Mar 2025.
What does Ampersand Biomedicines do?
Based in Massachusetts, US, and founded in 2020 by Noubar Afeyan, Ampersand Biomedicines, Inc.
Where is Ampersand Biomedicines headquartered?
Ampersand Biomedicines is headquartered in Boston, US.
Which VCs invest in companies like Ampersand Biomedicines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ampersand Biomedicines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Ampersand Biomedicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.